#epcoritamab — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #epcoritamab, aggregated by home.social.
-
AbbVie TEPKINLY approved in EU for follicular lymphoma
TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #epcoritamab #follicularlymphoma #marketingauthorization #oncology #TEPKINLY
https://www.europesays.com/europe/87729/